Hecto Innovation Co Ltd
KOSDAQ:214180
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hecto Innovation Co Ltd
KOSDAQ:214180
|
KR |
|
K
|
Kwung's Holdings Ltd
HKEX:1925
|
CN |
|
Xenetic Biosciences Inc
NASDAQ:XBIO
|
US |
|
Af Legal Group Ltd
ASX:AFL
|
AU |
|
Nordic Entertainment Group AB
OTC:NENTF
|
SE |
|
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
CN |
|
I
|
IG Group Holdings PLC
OTC:IGGRF
|
UK |
|
M
|
Medican Enterprises Inc
OTC:MDCN
|
US |
|
F
|
First Interstate BancSystem Inc
NASDAQ:FIBK
|
US |
|
Wallbridge Mining Company Ltd
TSX:WM
|
CA |
|
Eltek Ltd
NASDAQ:ELTK
|
IL |
|
S
|
Stalprofil SA
WSE:STF
|
PL |
|
F
|
Fadu Inc
KOSDAQ:440110
|
KR |
|
F
|
Foosung Co Ltd
KRX:093370
|
KR |
|
Galata Wind Enerji Anonim Sirket
IST:GWIND.E
|
TR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hecto Innovation Co Ltd's stock price target?
Not Available
Hecto Innovation Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hecto Innovation Co Ltd's Revenue forecast?
Projected CAGR
17%
For the last 12 years the compound annual growth rate for Hecto Innovation Co Ltd's revenue is 37%. The projected CAGR for the next 3 years is 17%.
What is Hecto Innovation Co Ltd's Operating Income forecast?
Projected CAGR
18%
For the last 12 years the compound annual growth rate for Hecto Innovation Co Ltd's operating income is 32%. The projected CAGR for the next 3 years is 18%.
What is Hecto Innovation Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 12 years the compound annual growth rate for Hecto Innovation Co Ltd's net income is 26%. The projected CAGR for the next 3 years is 21%.
